{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:28:58Z","timestamp":1747232938085},"reference-count":55,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2020,2,14]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>South Africa is considered the epicenter of HIV\/AIDS with a high rate of TB infection as well. Links have been established between treatments of these conditions to ototoxicity. However, no standardized and systematic ototoxicity monitoring exists within the clinical sites where these conditions are treated, with very minimal and adhoc involvement of audiologists as part of the treatment team. With 3.4 million HIV-infected South Africans being reported to have been on antiretroviral drugs by the end of March 2016; with universal coverage being the target, it is important that ototoxicity monitoring becomes part of the treatment plan. The objective of the current paper is to propose an ototoxicity monitoring protocol that can be implemented within this population to ensure that systematic data are collated in order for evidence-based protocols to be adopted within the South African context. Such a protocol will also allow for early identification and intervention of ototoxic hearing loss within this population. Enough evidence exists to support implementation of standardized protocols that will allow for proper, accurate, efficient, and reliable comparisons of data within and between patients; as well as between and within treatment sites \u2013 both locally and internationally. It is hoped that implementation of such a monitoring protocol will also have significant implications for the expanded role of the audiologist in the drug development process, affording evidence-based benefit-risk assessments of drugs in the market for this population. .<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871526518666181016102102","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:08:13Z","timestamp":1539691693000},"page":"33-42","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV\/Aids: Ototoxicity Monitoring Protocol Recommendation"],"prefix":"10.2174","volume":"20","author":[{"given":"Katijah","family":"Khoza-Shangase","sequence":"first","affiliation":[{"name":"Department of Speech Pathology and Audiology, School of Human and Community Development, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2019","unstructured":"HIV\/AIDS UNAIDSAvailable from : ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.unaids.org\/en\/resources\/fact-sheet\">http:\/\/www.unaids.org\/en\/resources\/fact-sheet2019","journal-title":"HIV\/AIDS"},{"key":"ref=2","author":"Shisana O.","year":"2014","unstructured":"Shisana O.; Rehle T.; Simbayi L.; South African national HIV prevalence, incidence and behaviour survey 24 July 2016. Available from : ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.hsrc.ac.za\/uploads\/pageContent\/4565\/SABSSM\">http:\/\/www.hsrc.ac.za\/uploads\/page Content\/4565\/SABSSM (Retrieved from Human Science Research Council)2014"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4102\/sajhivmed.v14i1.104","volume":"14","author":"Davies N.E.C.G.","year":"2013","unstructured":"Davies N.E.C.G.; Fixed-dose combination for adults accessing antiretroviral therapy. South Afr J HIV Med 2013,14(1),41-43","journal-title":"South Afr J HIV Med"},{"key":"ref=4","volume":"2030","year":"2014","unstructured":"UNAIDS sets 90-90-90 target for 2020 to end. AIDS UNAIDSAvailable from: ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/i-base.info\/htb\/27174\">http:\/\/i-base.info\/htb\/271742014,2030","journal-title":"AIDS"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1055\/s-2001-19111","volume":"22","author":"Lonsbury-Martin B.L.","year":"2001","unstructured":"Lonsbury-Martin B.L.; Martin G.K.; Evoked Otoacoustic emissions as objective screeners for ototoxicity. Semin Hear 2001,22,4","journal-title":"Semin Hear"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1524-4733.2010.00725.x","volume":"13","author":"Guo J.J.","year":"2010","unstructured":"Guo J.J.; Pandey S.; Doyle J.; Bian B.; Lis Y.; Raisch D.W.; A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. Value Health 2010,13(5),657-666","journal-title":"Value Health"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-0028-1082965","volume":"19","author":"Bankaitis A.E.","year":"1998","unstructured":"Bankaitis A.E.; Schountz T.; HIV-related ototoxicity. Semin Hear 1998,19,155-163","journal-title":"Semin Hear"},{"key":"ref=8","first-page":"574","volume":"4","author":"Khoza-Shangase K.","year":"2010","unstructured":"Khoza-Shangase K.; Is there a need for ototoxicity monitoring in patients with HIV\/AIDS? Afr J Pharm Pharmacol 2010,4(9),574-579","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00002018-200427080-00004","volume":"27","author":"Tsintis P.","year":"2004","unstructured":"Tsintis P.; La Mache E.; CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications. Drug Saf 2004,27(8),509-517","journal-title":"Drug Saf"},{"key":"ref=10","first-page":"2141","volume":"7","author":"Khoza-Shangase K.","year":"2013","unstructured":"Khoza-Shangase K.; Ototoxicity in tuberculosis treatment in south africa: views from healthcare workers involved in the management of TB. Afr J Pharm Pharmacol 2013,7(30),2141-2145","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref=11","first-page":"1","volume":"1","author":"Khoza-Shangase K.","year":"2016","unstructured":"Khoza-Shangase K.; Stirk M.; Audiological testing for ototoxicity monitoring in adults with Tuberculosis in state hospitals in Gauteng, South Africa. S Afr J Infect Dis 2016,1(1),1-6","journal-title":"S Afr J Infect Dis"},{"key":"ref=12","first-page":"49-65","author":"Blaschke T.F.","year":"1995","unstructured":"Blaschke T.F.; Nies A.S.; Mamelok R.D.; Principles of Therapeutics. Goodman and Gilman\u2019s The pharmacological basis of therapeutics 1995,49-65","journal-title":"Goodman and Gilman\u2019s The pharmacological basis of therapeutics"},{"key":"ref=13","author":"Kallail K.J.","unstructured":"Kallail K.J.; Downs D.W.; Schertz J.W.; Communication disorders in individuals with HIV\/AIDS. Kansas Journal of Medicine, 200 62-69. Available from : ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/archie.kumc.edu\/bitstream\/handle\/2271\/344\/Communication+Disorders+in+Individuals+with+HIV-AIDS.pdf?sequence\">http:\/\/archie.kumc.edu\/bitstream\/handle\/2271\/344\/Communication+Disorders+in+Individuals+with+HIV-AIDS.pdf?sequence","journal-title":"Kansas Journal of Medicine, 200"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24966\/ACRS-7370\/100001","volume":"1","author":"Khoza-Shangase K.","year":"2014","unstructured":"Khoza-Shangase K.; Pharmaco-audiology vigilance and highly active antiretroviral therapy (HAART) in South Africa: Ototoxicity Monitoring Pursued. J AIDS Clin Res Sexually Trans Dis 2014,1(1),1-10","journal-title":"J AIDS Clin Res Sexually Trans Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/0975-7406.76494","volume":"3","author":"Khoza-Shangase K.","year":"2011","unstructured":"Khoza-Shangase K.; Highly active antiretroviral therapy: Does it sound toxic? J Pharm Bioallied Sci 2011,3(1),142-153","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF00454229","volume":"228","author":"Bernard P.A.","year":"1980","unstructured":"Bernard P.A.; P\u00e9ch\u00e8re J.C.; H\u00e9bert R.; Altered objective audiometry in aminoglycosides-treated human neonates. Arch Otorhinolaryngol 1980,228(3),205-210","journal-title":"Arch Otorhinolaryngol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1003074","volume":"20","author":"Piek J.","year":"1985","unstructured":"Piek J.; Lumenta C.B.; Bock W.J.; Monitoring of auditory function in comatose patients in therapy with potentially ototoxic substances using acoustically evoked brainstem potentials. Anasth Intensivther Notfallmed 1985,20(1),1-5","journal-title":"Anasth Intensivther Notfallmed"},{"key":"ref=18","first-page":"105","volume":"2","author":"Fausti S.A.","year":"1991","unstructured":"Fausti S.A.; Rappaport B.Z.; Frey R.H.; Henry J.A.; Phillips D.S.; Mitchell C.R.; Olson D.J.; Reliability of evoked responses to high-frequency (8-14 kHz) tone bursts. J Am Acad Audiol 1991,2(2),105-114","journal-title":"J Am Acad Audiol"},{"key":"ref=19","first-page":"397","volume":"3","author":"Fausti S.A.","year":"1992","unstructured":"Fausti S.A.; Frey R.H.; Henry J.A.; Olson D.J.; Schaffer H.I.; Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses. J Am Acad Audiol 1992,3(6),397-404","journal-title":"J Am Acad Audiol"},{"key":"ref=20","author":"Campbell K.C.M.","year":"2007","unstructured":"Campbell K.C.M.; Pharmacology and ototoxicity for Audiologists 2007","journal-title":"Pharmacology and ototoxicity for Audiologists"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0165-5876(99)00247-5","volume":"50","author":"Stavroulaki P.","year":"1999","unstructured":"Stavroulaki P.; Apostolopoulos N.; Dinopoulou D.; Vossinakis I.; Tsakanikos M.; Douniadakis D.; Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 1999,50(3),177-184","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","volume":"20","author":"Fausti S.A.","year":"1999","unstructured":"Fausti S.A.; Henry J.A.; Helt W.J.; Phillips D.S.; Frey R.H.; Noffsinger D.; Larson V.D.; Fowler C.G.; An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear 1999,20(6),497-505","journal-title":"Ear Hear"},{"key":"ref=23","first-page":"567","volume":"39","author":"Vaughan N.E.","year":"2002","unstructured":"Vaughan N.E.; Fausti S.A.; Chelius S.; Phillips D.; Helt W.; Henry J.A.; An efficient test protocol for identification of a limited, sensitive frequency test range for early detection of ototoxicity. J Rehabil Res Dev 2002,39(5),567-574","journal-title":"J Rehabil Res Dev"},{"key":"ref=24","author":"Bess F.H.","year":"1990","unstructured":"Bess F.H.; Humes L.E.; Audiology: The fundamentals 1990","journal-title":"Audiology: The fundamentals"},{"key":"ref=25","author":"Hall J.W.","year":"2000","unstructured":"Hall J.W.; Handbook of otoacoustic emissions 2000","journal-title":"Handbook of otoacoustic emissions"},{"key":"ref=26","first-page":"63","volume":"174","author":"Friedmann I.","year":"1994","unstructured":"Friedmann I.; Arnold W.; Pathology of the ear. J Pathol 1994,174,63","journal-title":"J Pathol"},{"key":"ref=27","author":"Katz J.","year":"2002","unstructured":"Katz J.; Handbook of clinical audiology 2002","journal-title":"Handbook of clinical audiology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1177\/000348948909801206","volume":"98","author":"Meyerhoff W.L.","year":"1989","unstructured":"Meyerhoff W.L.; Maale G.E.; Yellin W.; Roland P.S.; Audiologic threshold monitoring of patients receiving ototoxic drugs. Preliminary report. Ann Otol Rhinol Laryngol 1989,98(12 Pt 1),950-954","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/bjc.1990.208","volume":"61","author":"Skinner R.","year":"1990","unstructured":"Skinner R.; Pearson A.D.J.; Amineddine H.A.; Mathias D.B.; Craft A.W.; Ototoxicity of cisplatinum in children and adolescents. Br J Cancer 1990,61(6),927-931","journal-title":"Br J Cancer"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/00206098909081626","volume":"28","author":"Dreschler W.A.","year":"1989","unstructured":"Dreschler W.A.; van der Hulst R.J.A.M.; Tange R.A.; Urbanus N.A.; Clinical Aspects. Role of high-frequency audiometry in the early detection of ototoxicity. II. Audiology 1989,28(4),211-220","journal-title":"Audiology"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.aud.0000233892.37803.1a","volume":"27","author":"Dreisbach L.E.","year":"2006","unstructured":"Dreisbach L.E.; Long K.M.; Lees S.E.; Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults. Ear Hear 2006,27(5),466-479","journal-title":"Ear Hear"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00003446-199012000-00007","volume":"11","author":"Frank T.","year":"1990","unstructured":"Frank T.; High-frequency hearing thresholds in young adults using a commercially available audiometer. Ear Hear 1990,11(6),450-454","journal-title":"Ear Hear"},{"key":"ref=33","first-page":"11","volume":"36","year":"1994","unstructured":"Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA American Speech-Language-Hearing Association1994,36(12),11-19","journal-title":"ASHA"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1288\/00005537-199108000-00005","volume":"101","author":"Feghali J.G.","year":"1991","unstructured":"Feghali J.G.; Bernstein R.S.; A new approach to serial monitoring of ultra-high frequency hearing. Laryngoscope 1991,101(8),825-829","journal-title":"Laryngoscope"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/00206099909073035","volume":"38","author":"Hall A.J.","year":"1999","unstructured":"Hall A.J.; Lutman M.E.; Methods for early identification of noise-induced hearing loss. Audiology 1999,38(5),277-280","journal-title":"Audiology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/03005364000000004","volume":"31","author":"Mulheran M.","year":"1997","unstructured":"Mulheran M.; Degg C.; Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects. Br J Audiol 1997,31(1),5-9","journal-title":"Br J Audiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/hn.1999.v121.a101567","volume":"121","author":"Ress B.D.","year":"1999","unstructured":"Ress B.D.; Sridhar K.S.; Balkany T.J.; Waxman G.M.; Stagner B.B.; Lonsbury-Martin B.L.; Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place--Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg 1999,121(6),693-701","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archotol.125.2.215","volume":"125","author":"Arnold D.J.","year":"1999","unstructured":"Arnold D.J.; Lonsbury-Martin B.L.; Martin G.K.; High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions. Arch Otolaryngol Head Neck Surg 1999,125(2),215-222","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1121\/1.418564","volume":"101","author":"Avan P.","year":"1997","unstructured":"Avan P.; Elbez M.; Bonfils P.; Click-evoked otoacoustic emissions and the influence of high-frequency hearing losses in humans. J Acoust Soc Am 1997,101(5 Pt 1),2771-2777","journal-title":"J Acoust Soc Am"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000227724","volume":"54","author":"Bir\u00f3 K.","year":"1997","unstructured":"Bir\u00f3 K.; Baki M.; B\u00fcki B.; Noszek L.; J\u00f3k\u00fati L.; Detection of early ototoxic effect in testicular-cancer patients treated with cisplatin by transiently evoked otoacoustic emission: a pilot study. Oncology 1997,54(5),387-390","journal-title":"Oncology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00003446-199212000-00008","volume":"13","author":"Franklin D.J.","year":"1992","unstructured":"Franklin D.J.; McCoy M.J.; Martin G.K.; Lonsbury-Martin B.L.; Test\/retest reliability of distortion-product and transiently evoked otoacoustic emissions. Ear Hear 1992,13(6),417-429","journal-title":"Ear Hear"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/010503999424743","volume":"28","author":"Zhao F.","year":"1999","unstructured":"Zhao F.; Stephens D.; Test-retest variability of distortion-product otoacoustic emissions in human ears with normal hearing. Scand Audiol 1999,28(3),171-178","journal-title":"Scand Audiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/010503900424507","volume":"29","author":"Beattie R.C.","year":"2000","unstructured":"Beattie R.C.; Ireland A.; Effects of sample size on the noise floor and distortion product otoacoustic emissions. Scand Audiol 2000,29(2),93-102","journal-title":"Scand Audiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3109\/14992020309101328","volume":"42","author":"Beattie R.C.","year":"2003","unstructured":"Beattie R.C.; Kenworthy O.T.; Luna C.A.; Immediate and short-term reliability of distortion-product otoacoustic emissions. Int J Audiol 2003,42(6),348-354","journal-title":"Int J Audiol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0030-6665(20)30774-X","volume":"26","author":"Campbell K.C.M.","year":"1993","unstructured":"Campbell K.C.M.; Durrant J.; Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am 1993,26(5),903-914","journal-title":"Otolaryngol Clin North Am"},{"key":"ref=46","first-page":"41","volume":"13","author":"Arlinger S.","year":"1981","unstructured":"Arlinger S.; Technical aspects on stimulation, recording and signal processing. Scand Audiol Suppl 1981,13,41-53","journal-title":"Scand Audiol Suppl"},{"key":"ref=47","first-page":"17","volume":"45","author":"Baer J.E.","year":"1992","unstructured":"Baer J.E.; Hall J.W.; Effects of nonpathologic factors on otoacoustic emissions. Hear J 1992,45,17-23","journal-title":"Hear J"},{"key":"ref=48","first-page":"496","author":"Jacobson J.T.","year":"1985","unstructured":"Jacobson J.T.; Hyde M.L.; Handbook of clinical audiology 1985,496-533","journal-title":"Handbook of clinical audiology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00003446-199808000-00007","volume":"19","author":"Popelka G.R.","year":"1998","unstructured":"Popelka G.R.; Karzon R.K.; Clary R.A.; Identification of noise sources that influence distortion product otoacoustic emission measurements in human neonates. Ear Hear 1998,19(4),319-328","journal-title":"Ear Hear"},{"key":"ref=50","year":"1996","unstructured":"GSI 60 DPOAE user manual. Milford NH: GSI Grason-Stadler 1996","journal-title":"NH: GSI Grason-Stadler"},{"key":"ref=51","author":"Martin F.N.","year":"2003","unstructured":"Martin F.N.; Clark J.G.; Introduction to audiology 2003","journal-title":"Introduction to audiology"},{"key":"ref=52","year":"2009","unstructured":"American Academy of Audiology. Position statement and clinical practice guidelines: Ototoxicity monitoring. Available from : ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.audiology.org\/resources\/documentlibrary\/Documents\/OtoMonPositionGuideline.pdf\">www.audiology.org\/resources\/documentlibrary\/Documents\/OtoMonPositionGuideline.pdf2009"},{"key":"ref=53","author":"Ludman L.","year":"1998","unstructured":"Ludman L.; Wright T.; Diseases of the ear 1998","journal-title":"Diseases of the ear"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10162-014-0448-x","volume":"15","author":"Le Prell C.G.","year":"2014","unstructured":"Le Prell C.G.; Ojano-Dirain C.; Rudnick E.W.; Nelson M.A.; DeRemer S.J.; Prieskorn D.M.; Miller J.M.; Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity. J Assoc Res Otolaryngol 2014,15(3),375-393","journal-title":"J Assoc Res Otolaryngol"},{"key":"ref=55","first-page":"391","volume":"3","author":"Wissink T.F.","year":"2006","unstructured":"Wissink T.F.; Moes C.; Beisel K.W.; Neurotrophins and Hearing Dysfunction: Comparing models to stop nerve fiber loss. Drug Discov Today 2006,3(4),391-396","journal-title":"Drug Discov Today"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:02:35Z","timestamp":1605243755000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166284\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526518666181016102102","relation":{},"ISSN":["1871-5265"],"issn-type":[{"value":"1871-5265","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}